mir2

Editor’s Choice
Main Category: Multiple Sclerosis
Also Included In: Fertility
Article Date: 12 Jun 2012 – 15:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

<!– rate icon rate article

Patient / Public:1 star

1 (1 votes)

Healthcare Prof:not yet rated

Although pregnancy and sex hormone therapy are known to influence the multiple sclerosis (MS) relapse rate, researchers have now found that women with MS are more likely to relapse if they undergo in vitro fertilization (IVF).

Women are significantly more likely to develop MS than men and results from the study, published online in the Journal of Neurology Neurosurgery and Psychiatry, indicate that hormones may play a role in MS.

The researchers set out to determine whether synthetic hormonal treatments used during assisted reproduction techniques might influence the relapse rate among women with MS.

The team examined 32 women with MS who underwent IVF between 1998 and 2008 at 13 French university hospitals.

In total, 70 cycles of IVF were carried out, of which 19 included gonadotrophin releasing hormone (GnRH) antagonists, and 48 GnRH agonists. These chemicals are designed to regulate the timing of the release of natural hormones needed to prompt the ovaries and womb to prepare for a pregnancy.?

The researchers found that women were considerably (60%) more likely to suffer a relapse in the three months after IVF treatment. In the three months after the 70 IVF procedures, 26 relapses occurred.

This figure increase to 71% when the time frame was reduce to two months. IVF failure and GnRH agonists both increased the risk of relapse, rather than antagonists.

The risk of relapse in the three months after treatment was 50% higher among the women who failed to get pregnant with IVF. 40% of women got pregnant with GnRH agonists vs 10% of women treated with GnRH antagonists.

According to the researchers, the stress of IVF could increase the risk of relapse, and may explain some of their findings. However, women suffering from MS who undergo IVF should be informed of the potential increase risk of relapse, particularly if the treatment does not result in pregnancy.

Written By Grace Rattue

Copyright: Medical News Today

Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

“Increased risk of multiple sclerosis relapse after in vitro fertilization
Laure Michel, Yohann Foucher, Sandra Vukusic, Christian Confavreux, Jérome de Sèze, David Brassat, Michel Clanet, Pierre Clavelou, Jean-Christophe Ouallet, Bruno Brochet, Jean Pelletier, Pierre Labauge, Christine Lebrun, Emmanuelle Lepage, Fabienne Le Frere, Marylène Jacq-Foucher, Paul Barriere, Sandrine Wiertlewski, David-Axel Laplaud
J Neurol Neurosurg Psychiatry , June 2012, doi:10.1136/jnnp-2012-302235

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA


Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

‘Multiple Sclerosis Patients Who Receive Fertility Treatment Have Higher Relapse Rates’

Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.

MediLexicon International Ltd Logo

Privacy Policy |
Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Everyday Health Network

back to top | home |
privacy policy

MediLexicon International Ltd Logo

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Article source: http://www.medicalnewstoday.com/articles/246489.php